Literature DB >> 3712042

Propranolol hydrochloride enhancement of tumor perfusion and uptake of gallium-67 in a mouse sarcoma.

P Bomber, R McCready, P Hammersley.   

Abstract

The effect of propranolol hydrochloride on the blood perfusion of a mouse sarcoma and other tissues has been studied using 86Rb. The maximum increase in relative tumor perfusion (2x controls) occurred 15 min after an i.v. administration of 10 mg per kg propranolol hydrochloride. To study the effect of this drug on the uptake of 67Ga, it was injected at a concentration of 10 mg/kg 10 min before administering 3 microCi (110 kBq) [67Ga]citrate. Tissue uptakes were measured 4 hr later. The tumor: blood ratio increased from 1.16 +/- 0.17 to 3.41 +/- 2.27 (s.d.) and tumor: liver ratio increased from 2.39 +/- 0.30 to 7.13 +/- 3.52 (s.d.). The results showed that propranolol hydrochloride can improve the relative tumor blood flow and radiopharmaceutical concentration in an animal model. It is hoped that this and other agents will yield similar results in the human situation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3712042

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

1.  Scheduling of anticancer drugs: timing may be everything.

Authors:  Astrid A M Van der Veldt; Adriaan A Lammertsma; Egbert F Smit
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

2.  99mTc-HMPAO as a tumour blood flow agent.

Authors:  P A Hammersley; V R McCready; J W Babich; G Coghlan
Journal:  Eur J Nucl Med       Date:  1987

3.  Biphasic effects of propranolol on tumour growth in B16F10 melanoma-bearing mice.

Authors:  Sonia Maccari; Maria Buoncervello; Andrea Rampin; Massimo Spada; Daniele Macchia; Luciana Giordani; Tonino Stati; Claudia Bearzi; Liviana Catalano; Roberto Rizzi; Lucia Gabriele; Giuseppe Marano
Journal:  Br J Pharmacol       Date:  2016-11-30       Impact factor: 8.739

4.  An examination of the influence of vasoactive drugs on blood flow and localisation of a monoclonal antibody in human tumour xenografts.

Authors:  M V Pimm
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

5.  Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent.

Authors:  Pan Pantziarka; Gauthier Bouche; Vidula Sukhatme; Lydie Meheus; Ilse Rooman; Vikas P Sukhatme
Journal:  Ecancermedicalscience       Date:  2016-10-12

6.  Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft model.

Authors:  G Rowlinson-Busza; A Maraveyas; A A Epenetos
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.